82 results
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
14 Jun 24
Condensed Consolidated Financial Statements
4:30pm
to the inherently unpredictable nature of preclinical and clinical development processes, we are unable to estimate with any certainty the costs we will incur … and actions that may impact us in the future, the estimation process is, by its nature, uncertain given that estimates depend on events over which we
6-K
EX-1.1
ENLV
Enlivex Therapeutics Ltd
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good … had not occurred.
5.17 Independent Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under any Transaction Document
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
and terms and conditions included in the contracts with the service providers. In addition, in certain circumstances, the determination of the nature … . The Company may invest its excess cash in mutual funds that are classified based on the nature of their underlying securities and their availability for use
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
that are classified based on the nature of their underlying securities and their availability for use in current operations. The Company’s marketable
6-K
EX-99.2
r9yck9p8 wx389v
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
rogtguoe1an x8cf
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
6-K
EX-99.1
viy59 qrfhl
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
6-K
EX-99.1
vzxd4owsoeq met1agx
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
7i1v9e55elt358
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
f9eeyl
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
j5nsuib88ginq5zlcc
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
bed8agb
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
EX-10.1
7zyci9xt
30 Dec 22
Report of Foreign Private Issuer
4:02pm
6-K
EX-99.1
odll73
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.2
4v69z3iwn4pfo
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.1
jsdm3 bd6x9yjcr
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
6-K
EX-99.1
vu92p
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.2
ct68qnwbjc7
22 Aug 22
Condensed Consolidated Financial Statements
8:08am